Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
40411-27-6Cc1ccc(Cl)cc1N=C=OXEMUTFNBAICJEO-UHFFFAOYSA-N40411-27-6DTXSID00377805Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H302 (88.6%): Harmful if swallowed [Warning Acute toxicity, oral]
P233, P260, P261, P264, P264+P265, P270, P271, P280, P284, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P342+P316, P362+P364, P403, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 44 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Verwenden5-Chloro-2-methylphenyl isocyanate may be used in the synthesis of:N-(5-chloro-2-methyphenyl)-N′-(1-methylethyl)-thioureaN-(5-chloro-2-methyphenyl)-N′-(1-methylethyl)-urea5-chloro-2-methylphenylcarbamoylated cyclodextrin (CD) chiral stationary phase (CSP)